Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by itntdfon Apr 01, 2024 1:34pm
233 Views
Post# 35963214

2 outta 3 ain't too bad, stay tuned.

2 outta 3 ain't too bad, stay tuned.

(1) we know that andrew de g “left”

(2) we now know that oncy leased a new office in san diego

US Office

4350 Executive Drive

Suite 325

San Diego, CA 92121

(3) probably not safe to assume this space is being rented just to give people working from home an office address so that they can appear legitimate. Imagine next announcement will be a new obus head to replace the now departed andrew.

Last january I posted:

On Friday, January 5, 2024 at 02:34:38 PM EST, Matt Coffey wrote:

Thank you for your note.

-------------------------------

 

Concerning Andrew’s employment, the Company decided it wanted a different skill set for this role going forward. We are actively looking to fill this role at this point. As Andrew was not an officer of the Company, there are no requirements to announce his departure, and indeed we don’t announce non-officer departures. This is again due to these roles being non-material to the organization. As a Company policy, we all sign a non-disparaging agreement, so we do not provide any colour around a person’s leaving. If someone were to ask for a reference for any of our ex-employees, we typically only give the period that the organization employed them.

_________________

With respect to his LinkedIn account, the Company cannot compel employees to update their status. Within the industry, it is not uncommon for employees looking for work to not update their profile until they have secured a new role to prevent the appearance of gaps in their resumes.

________________

Regarding the California office, our lease expired, so we are moving to a new location about two blocks from the current office. Unlike the old office, this one is more work-friendly, bigger from a square footage perspective, and cheaper. Again, as this is a non-material, non-strategic event, we would not plan to announce moving offices within the same neighbourhood.

_____________________

I will speak with LSA about Tim’s apparently curt responses.

__________________

I have cc’ed Jon Patton should you wish to discuss any of these issues with him further.

________________

Regards,

Matt

________________

then cf posted:

 

Comment by canadafanon Jan 05, 2024 11:51pm

185 Views Post# 35813524

RE:shareholder interaction 101, note taking, not a doormat

That is a pile of artistic creativity.

You got ahold of Mstt how?

" diiffernt skill set" ....yet " can't discuss employees leaving"

Perhaps a fantasy of yours,

total none sense


<< Previous
Bullboard Posts
Next >>